Ampio Pharmaceuticals
AMPE
#11317
Rank
A$0.31 M
Marketcap
A$0.28
Share price
0.00%
Change (1 day)
1,695.31%
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -A$12.93 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -A$24.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -A$13.05 Million-47.14%
2022 -A$24.68 Million-4.36%
2021 -A$25.8 Million7.42%
2020 -A$24.02 Million16.62%
2019 -A$20.6 Million-140.1%
2018 A$51.34 M-165.49%
2017 -A$78.4 Million170.77%
2016 -A$28.96 Million-30.16%
2015 -A$41.46 Million-29.73%
2014 -A$59 Million59.2%
2013 -A$37.06 Million111.58%
2012 -A$17.52 Million-36.57%
2011 -A$27.62 Million127.2%
2010 -A$12.16 Million758.38%
2009 -A$1.42 Million3105.94%
2008 -A$0.05 Million0.79%
2007 -A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B-216,979.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B-80,822.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.90 B-83,719.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$8.59 B-65,980.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
A$0.13 B-1,158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$35.12 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA